Table 1.
Clinicopathological characteristics | Number of cases | CCR7 | Statistical analysis | STAT3 phosphorylation | Statistical analysis | ||
---|---|---|---|---|---|---|---|
+~+++ | − | +~+++ | − | ||||
Age | |||||||
≥60 | 40 | 25 | 15 | χ 2 = 0.032 | 25 | 15 | χ 2 = 0.422 |
<60 | 38 | 23 | 15 | 21 | 17 | ||
Gender | |||||||
Male | 50 | 32 | 18 | χ 2 = 0.357 | 30 | 20 | χ 2 = 0.061 |
Female | 28 | 16 | 12 | 16 | 12 | ||
Tumor size | |||||||
T1, T2 | 65 | 37 | 28 | χ 2 = 3.510 | 36 | 29 | χ 2 = 2.077 |
T3, T4 | 13 | 11 | 2 | 10 | 3 | ||
Clinical stage | |||||||
I, II | 37 | 15 | 22 | χ 2 = 13.113∗ | 14 | 23 | χ 2 = 12.998∗ |
III, IV | 41 | 33 | 8 | 32 | 9 | ||
Nodal metastasis | |||||||
Yes | 37 | 29 | 8 | χ 2 = 8.434∗ | 29 | 8 | χ 2 = 10.954∗ |
No | 41 | 19 | 22 | 17 | 24 |
* P < 0.05 (the internal difference of CCR7 or STAT3 phosphorylation expression within clinicopathological characteristics).